Risk factor
Negligible price volatility
Profitability factor
Overvalued vs peers
About
Borregaard ASA, established in 2012 and headquartered in Sarpsborg, Norway, is a global enterprise focused on the development, production, and marketing of specialized biomaterials, biochemicals, and biofuels. Its market presence extends across Norway, the broader European region, the United States, Asia, and various other international territories. The company's operations are structured around three distinct divisions: BioSolutions, BioMaterials, and Fine Chemicals. The BioSolutions segment provides biopolymers crucial for numerous applications, including agrochemicals, battery manufacturing, industrial binding, and construction. This division also supplies biovanillin to the flavor and fragrance industries, as well as the food and beverage sector. In the BioMaterials segment, Borregaard offers specialty cellulose, utilized as a raw material in the production of items such as cellulose ethers, cellulose acetate, and other specialized products. It further manufactures cellulose fibrils for diverse industrial purposes. Lastly, the Fine Chemicals segment delivers fine chemical intermediates, particularly for contrast agents, in addition to bioethanol.
Company Valuation
From both historical and forecast perspectives, the stock is overpriced compared to similar stocks. In particular, the stock is overpriced on P/E, of fair value on EV/EBI
Target Price
The average target price of BRG.OL is 166 and suggests 10.3% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendati